非洲幼儿促炎与调节性细胞因子平衡与临床疟疾低风险相关
本研究基于莫桑比克一项双盲随机安慰剂对照试验,用磺胺多辛-乙胺嘧啶加青蒿琥酯每月预防性用药选择性控制婴儿期疟疾暴露。结果显示,生命第二年较高的促炎(IL-1、IL-6、TNF)和调节性(IL-10)细胞因子浓度与4岁前临床疟疾发病率降低相关;预防性用药组2岁前抗原特异性Th1和Th2细胞因子浓度显著低于安慰剂组。
要点
- 生命第二年促炎与调节性细胞因子平衡与4岁前临床疟疾低风险相关
- 婴儿期选择性化学预防显著影响1年后的Th淋巴细胞细胞因子产生
- 预防性用药组2岁前抗原特异性Th1和Th2细胞因子浓度显著低于安慰剂组
核心结论
- 生命第二年较高的促炎和调节性细胞因子浓度与4岁前临床疟疾发病率降低相关。
研究设计与样本
- 莫桑比克双盲随机安慰剂对照试验,用磺胺多辛-乙胺嘧啶加青蒿琥酯每月化学预防选择性控制婴儿期疟疾暴露。
- 采集2.5、5.5、10.5、15和24月龄外周血单核细胞,用裂殖体和红细胞裂解物体外刺激。
- 用逆转录定量PCR和多重流式细胞术分别定量细胞因子mRNA和分泌蛋白。
- 儿童从出生随访临床疟疾至4岁。
主要发现
- 生命第二年较高的促炎(IL-1、IL-6、TNF)和调节性(IL-10)细胞因子浓度与4岁前临床疟疾发病率降低相关,校正化学预防和既往疟疾暴露。
- 化学预防组2岁前抗原特异性Th1(IL-2、IL-12、IFN-γ)和Th2(IL-4、IL-5)细胞因子浓度显著低于安慰剂组(P < .03)。
临床怎么用
- 生命早期促炎与调节性细胞因子平衡可能作为临床疟疾保护性免疫的参考标志。
- 婴儿期化学预防可显著改变后续Th淋巴细胞细胞因子产生,评估免疫干预时需考虑暴露时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of timing of exposure to first Plasmodium falciparum infections during early childhood on the induction of innate and adaptive cytokine responses and their contribution to the development of clinical malaria immunity is not well established. METHODS: As part of a double-blind, randomized, placebo-controlled trial in Mozambique using monthly chemoprophylaxis with sulfadoxine-pyrimethamine plus artesunate to selectively control timing of malaria exposure during infancy, peripheral blood mononuclear cells collected from participants at age 2.5, 5.5, 10.5, 15, and 24 months were stimulated ex vivo with parasite schizont and erythrocyte lysates. Cytokine messenger RNA expressed in cell pellets and proteins secreted in supernatants were quantified by reverse-transcription quantitative polymerase chain reaction and multiplex flow cytometry, respectively. Children were followed up for clinical malaria from birth until 4 years of age. RESULTS: Higher proinflammatory (interleukin [IL] 1, IL-6, tumor necrosis factor) and regulatory (IL-10) cytokine concentrations during the second year of life were associated with reduced incidence of clinical malaria up to 4 years of age, adjusting by chemoprophylaxis and prior malaria exposure. Significantly lower concentrations of antigen-specific T-helper 1 (IL-2, IL-12, interferon-γ) and T-helper 2 (IL-4, IL-5) cytokines by 2 years of age were measured in children undergoing chemoprophylaxis compared to children receiving placebo (P < .03). CONCLUSIONS: Selective chemoprophylaxis altering early natural exposure to malaria blood stage antigens during infancy had a significant effect on T-helper lymphocyte cytokine production >1 year later. Importantly, a balanced proinflammatory and anti-inflammatory cytokine signature, probably by innate cells, around age 2 years was associated with protective clinical immunity during childhood. CLINICAL TRIALS REGISTRATION: NCT00231452.
引用
- Dobaño C, Nhabomba AJ, Manaca MN, et al. A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical Malaria. Clin Infect Dis. 2019. PMID: 30380038. doi:10.1093/cid/ciy934
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。